These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 21497460)

  • 1. Determination of minimum inhibitory and minimum bactericidal concentrations of tiamulin against field isolates of Actinobacillus pleuropneumoniae.
    Pridmore A; Burch D; Lees P
    Vet Microbiol; 2011 Aug; 151(3-4):409-12. PubMed ID: 21497460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potency of marbofloxacin for pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida: Comparison of growth media.
    Dorey L; Hobson S; Lees P
    Res Vet Sci; 2017 Apr; 111():43-48. PubMed ID: 27940285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of florfenicol for Actinobacillus pleuropneumoniae and Pasteurella multocida using standardised versus non-standardised methodology.
    Dorey L; Hobson S; Lees P
    Vet J; 2016 Dec; 218():65-70. PubMed ID: 27938711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Susceptibility testing of Actinobacillus pleuropneumoniae in Denmark. Evaluation of three different media of MIC-determinations and tablet diffusion tests.
    Aarestrup FM; Jensen NE
    Vet Microbiol; 1999 Feb; 64(4):299-305. PubMed ID: 10063535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proposed quality control guidelines for National Committee for Clinical Laboratory Standards Susceptibility Tests using the veterinary antimicrobial agent tiamulin.
    Pfaller MA; Jones RN; Walter DH;
    Diagn Microbiol Infect Dis; 2001; 40(1-2):67-70. PubMed ID: 11448566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial susceptibility of Actinobacillus pleuropneumoniae isolated from pigs in Korea using new standardized procedures.
    Kim B; Min K; Choi C; Cho WS; Cheon DS; Kwon D; Kim J; Chae C
    J Vet Med Sci; 2001 Mar; 63(3):341-2. PubMed ID: 11307940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative in vitro activity of 16 antimicrobial agents against Actinobacillus pleuropneumoniae.
    Yoshimura H; Takagi M; Ishimura M; Endoh YS
    Vet Res Commun; 2002 Jan; 26(1):11-9. PubMed ID: 11860083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial susceptibility of Actinobacillus pleuropneumoniae isolates from clinical outbreaks of porcine respiratory diseases.
    Kucerova Z; Hradecka H; Nechvatalova K; Nedbalcova K
    Vet Microbiol; 2011 May; 150(1-2):203-6. PubMed ID: 21316872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of tildipirosin in porcine plasma, lung tissue, and bronchial fluid and effects of test conditions on in vitro activity against reference strains and field isolates of Actinobacillus pleuropneumoniae.
    Rose M; Menge M; Bohland C; Zschiesche E; Wilhelm C; Kilp S; Metz W; Allan M; Röpke R; Nürnberger M
    J Vet Pharmacol Ther; 2013 Apr; 36(2):140-53. PubMed ID: 22500881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serological characterisation and antimicrobial susceptibility of Actinobacillus pleuropneumoniae strains isolated from pigs in Spain.
    Gutiérrez CB; Rodríguez Barbosa JI; Tascón RI; Costa L; Riera P; Rodríguez Ferri EF
    Vet Rec; 1995 Jul; 137(3):62-4. PubMed ID: 8533233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sub-inhibitory concentrations of penicillin G induce biofilm formation by field isolates of Actinobacillus pleuropneumoniae.
    Hathroubi S; Fontaine-Gosselin SÈ; Tremblay YD; Labrie J; Jacques M
    Vet Microbiol; 2015 Sep; 179(3-4):277-86. PubMed ID: 26130517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of growth matrix on pharmacodynamics of antimicrobial drugs for pig pneumonia pathogens.
    Dorey L; Lees P
    BMC Vet Res; 2017 Jun; 13(1):192. PubMed ID: 28645327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors influencing the potency of marbofloxacin for pig pneumonia pathogens Actinobacillus pleuropneumoniae and Pasteurella multocida.
    Dorey L; Hobson S; Lees P
    Res Vet Sci; 2017 Apr; 111():93-98. PubMed ID: 28113129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Standardization of broth microdilution and disk diffusion susceptibility tests for Actinobacillus pleuropneumoniae and Haemophilus somnus: quality control standards for ceftiofur, enrofloxacin, florfenicol, gentamicin, penicillin, tetracycline, tilmicosin, and trimethoprim-sulfamethoxazole.
    McDermott PF; Barry AL; Jones RN; Stein GE; Thornsberry C; Wu CC; Walker RD
    J Clin Microbiol; 2001 Dec; 39(12):4283-7. PubMed ID: 11724833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial susceptibilities and resistance genes of Canadian isolates of Actinobacillus pleuropneumoniae.
    Archambault M; Harel J; Gouré J; Tremblay YD; Jacques M
    Microb Drug Resist; 2012 Apr; 18(2):198-206. PubMed ID: 22204596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial susceptibility of Actinobacillus pleuropneumoniae, Pasteurella multocida and Salmonella choleraesuis isolates from pigs.
    Raemdonck DL; Tanner AC; Tolling ST; Michener SL
    Vet Rec; 1994 Jan; 134(1):5-7. PubMed ID: 8128570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial resistance of Actinobacillus pleuropneumoniae isolated from swine.
    Vanni M; Merenda M; Barigazzi G; Garbarino C; Luppi A; Tognetti R; Intorre L
    Vet Microbiol; 2012 Apr; 156(1-2):172-7. PubMed ID: 22104584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility of bacteria isolated from pigs to tiamulin and enrofloxacin metabolites.
    Lykkeberg AK; Halling-Sørensen B; Jensen LB
    Vet Microbiol; 2007 Mar; 121(1-2):116-24. PubMed ID: 17194550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility to pleuromutilins in Brachyspira (Serpulina) hyodysenteriae.
    Karlsson M; Gunnarsson A; Franklin A
    Anim Health Res Rev; 2001 Jun; 2(1):59-65. PubMed ID: 11708748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tiamulin activity against fastidious and nonfastidious veterinary and human bacterial isolates: initial development of in vitro susceptibility test methods.
    Jones RN; Pfaller MA; Rhomberg PR; Walter DH
    J Clin Microbiol; 2002 Feb; 40(2):461-5. PubMed ID: 11825957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.